Abstract:OBJECTIVE:To investigate nerve fibers distribution in endometrium of adenomyosis and their relationship with dysmenorrhea.METHODS:Endometrial tissue was sampled from 74 hysterectomy specimens including 32 cases with adenomyosis and 42 cases with uterine fibroids. Two-step Envision immunohistochemical staining was used to detect distribution of nerve fibers in endometrium. Highly specific polyclonal rabbit anti-protein gene product 9.5 (PGP9.5) and monoclonal mouse anti-neurofilament protein (NF) were used to demonstrate both myelinated and unmyelinated nerve fibers in endometrium in women with adenomyosis and uterine fibroids.RESULTS:The positive rate of PGP9.5 immunoreactive nerve fibers in the functional layer of endometrium of pain patients were with 64% (14/22) in adenomyosis and 67% (10/15) in uterine fibroids. And their density were 0.6 (0 - 9.4)/mm(2) and 0.6 (0 - 6.0)/mm(2) without reaching statistical difference (P > 0.05). No expression of NF could be detected in the functional layer of endometrium of adenomyosis and uterine fibroids. There were no PGP9.5 immunoreactive nerve fibers in the functional layer of endometrium in non-pain women with adenomyosis and uterine fibroids. Moreover, No NF immunoreactive nerve fibers in the functional layer of endometrium were shown in non-pain patients with adenomyosis and uterine fibroids. PGP9.5 immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 64% (14/22), 1.1 (0 - 12.0)/mm(2) in pain adenomyosis and 50% (5/10), 0.6 (0 - 3.0)/mm(2) in non-pain adenomyosis. NF immunoreactive nerve fibers and the density in the basal layer of endometrium were 23% (5/22), (0 - 0.6)/mm(2) in pain adenomyosis and 20% (2/10), (0 - 1.0)/mm(2) in non-pain adenomyosis. PGP9.5 immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 80% (12/15) and 1.6 (0 - 10.0)/mm(2) in pain fibroids and 44% (12/27), 0 (0 - 5.0)/mm(2) in non-pain fibroids. NF immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 40% (6/15), 0 (0 - 0.4)/mm(2) in pain fibroids and 15% (4/27), 0 (0 - 1.0)/mm(2) in non-pain fibroids. There was no statistical different PGP9.5 and NF immunoreactive nerve fibers distribution in basal layer of endometrium between pain adenomyosis and pain fibroids or between non-pain adenomyosis and non-pain fibroids (all P > 0.05). However, PGP9.5 immunoreactive nerve fibers density in basal layer of endometrium was higher in pain adenomyosis and fibroids when compared with non-pain adenomyosis and fibroids (P < 0.05).CONCLUSIONS:PGP9.5 immunoreactive nerve fibers might confer the occurrence of pelvic pain, however, NF immunoreactive nerve fibers may not involved in the pathogenesis of pain.

Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis

[The role of inflammatory and immune reactivity in developing pain in adenomyosis]

Innervation of Endometrium and Myometrium in Women with Painful Adenomyosis and Uterine Fibroids.

Proangiogenic features in chronic pelvic pain caused by adenomyosis

[Distribution of Nerve Fibers in Endometrium and Its Clinical Significance in Adenomyosis].

Endometrial Nerve Fibers in Women with Endometriosis, Adenomyosis, and Uterine Fibroids

Protein gene product 9.5-immunoactive nerve fibers and its clinical significance in endometriotic peritoneal lesions

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

Nerve Fibres in Ovarian Endometriotic Lesions in Women with Ovarian Endometriosis

Immunoreactivity of CD 68 , granulocyte-macrophage colony-stimulating factors receptor and vonWillebrand factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis

Association of Uterine Tissue Innervation and Peripheral Nerve Density with Adenomyosis Related Pain. A Systematic Review

Dysmenorrhea in Patients with Adenomyosis: A Clinical and Demographic Study.

Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window after Ovarian Stimulation

Pathogenesis of Adenomyosis: an Update on Molecular Mechanisms.

Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology

Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis.

Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis

Transforming growth factor beta-1 (TGF-β1) expression in patients with adenomyosis

Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis

Endometriotic Pain Is Associated with Adenomyosis but Not with the Compartments Affected by Deep Infiltrating Endometriosis

Clinical characteristics and outcomes of women with adenomyosis pain during pregnancy: a retrospective study